Recordati reports FY2025 results
Source: SeekingAlpha
2026-02-18 13:34:42 ET
More on Recordati Industria Chimica e Farmaceutica S.p.A.
- Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) Q4 2025 Earnings Call Transcript
- Recordati Industria Chimica e Farmaceutica S.p.A. 2025 Q4 - Results - Earnings Call Presentation
- Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Recordati Industria Chimica e Farmaceutica S.p.A.
- Historical earnings data for Recordati Industria Chimica e Farmaceutica S.p.A.
Read the full article on Seeking Alpha
For further details see:
Recordati reports FY2025 results
Recordati Industria Chim
NASDAQ: RCDTF
RCDTF Trading
0.0% G/L:
$56.95 Last:
100 Volume:
$56.95 Open:
RCDTF Latest News
February 17, 2026 12:18:11 pm
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
January 29, 2026 05:19:55 pm
RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA
